Gene ID number
7040
Modification site
None
Conjugation
Cy5.5
Crossreactivity
Human
Swiss Prot
P01137
Subcellular location
Secreted
Tested applications
IF(IHC-P)
French translation
anticorps
Target Antigen
TGF beta 1
Modification
Unmodified
Clonality
Polyclonal
Concentration
1ug per 1ul
Excitation Emission
675nm/694nm
Additional conjugation
Cy5.5,Cy5.5
Immunogen_range
100-150/390
Recommended dilutions
IF(IHC-P)(1:50-200)
Clone
Polyclonal antibody
Category
Conjugated Primary Antibodies
Host Organism
Rabbit (Oryctolagus cuniculus)
Purification method
This antibody was purified via Protein A.
Long name
TGF beta 1 Polyclonal Antibody, Cy5.5 Conjugated
Specificity
This is a highly specific antibody against TGF beta 1.
Source
KLH conjugated synthetic peptide derived from human TGF beta 1/LAP
Synonyms
CED; LAP; DPD1; TGFB; TGFbeta; Transforming growth factor beta-1; TGF-beta-1; TGFB1
Conjugated
These antibodies are excite for emission at 678nm and detected at a 694 nm wavelengths.
Crossreactive species details
Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.
Storage conditions
Keep the antibody in an aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store refrigerated at 2 to 8 degrees Celcius for up to 1 year.
Properties
If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor.
Antigen background
Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner. At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development. At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells.